Evaluation of Glycemic Control Metrics for Intensive Care Unit Populations-Reference-Cited by-同舟云学术

Evaluation of Glycemic Control Metrics for Intensive Care Unit Populations

Published:2009-06-09 Issue:4 Volume:24 Page:310-320
ISSN:1062-8606
Container-title:American Journal of Medical Quality
language:en
Short-container-title:Am J Med Qual

Author:

Badawi Omar¹,Yeung Siu Yan²,Rosenfeld Brian A.³

Affiliation:

1. Philips VISICU, Department of Research and Development, University of Maryland School of Pharmacy, Department of Pharmacy Practice and Science, Baltimore, Maryland,

2. University of Maryland Medical Center, Department of Pharmacy

3. Philips VISICU, Department of Clinical Transformation, Baltimore, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.1177/1062860609336366

Reference40 articles.

1. Quality of Care in U.S. Hospitals as Reflected by Standardized Measures, 2002–2004

2. Care in U.S. Hospitals — The Hospital Quality Alliance Program

3. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value of Glycemic Indices for Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Retrospective Single-Center Study;Brain Sciences;2024-08-23

2. Relationship between time-weighted average glucose and mortality in critically ill patients: a retrospective analysis of the MIMIC-IV database;Scientific Reports;2024-02-27

3. Hyperglycemia is associated with worse 3-year survival in older patients admitted to the intensive care unit after non-cardiac surgery: Post hoc analysis of a randomized trial;Frontiers in Medicine;2022-12-12

4. Glycemic control in critically ill patients with or without diabetes;BMC Anesthesiology;2022-07-16

5. Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial;INTENS CARE MED;2021